Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Glauser

Showing results (231-240 of 243) with videos related to

Pageof 25
Sort By:
European Heart Journal|October 1, 1985
Prophylaxis of infective endocarditis for dental procedures. Report of a working party of the European Society of CardiologyJ Delaye, J Etienne, G A Feruglio, et al.
Circulation|August 18, 1999
Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort StudyD Périard, A Telenti, P Sudre, et al.
Critical Care Medicine|July 9, 1999
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patientsP Eggimann, P Francioli, J Bille, et al.
Lancet (London, England)|July 13, 1985
Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipidJ D Baumgartner, M P Glauser, J A McCutchan, et al.
Critical Care Medicine|April 1, 1997
Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumoniaI de Werra, C Jaccard, S B Corradin, et al.
JAMA|May 21, 1997
p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study GroupE Abraham, M P Glauser, T Butler, et al.
The Pediatric Infectious Disease Journal|August 1, 1996
Empirical treatment of fever in neutropenic children: the role of the carbapenems. International Antimicrobial Therapy Cooperative Group of the European Organisation for Research and Treatment of Cancer and the Gimema Infection ProgramA Cometta, C Viscoli, E Castagnola, et al.
Antimicrobial Agents and Chemotherapy|October 31, 1998
Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitisC Jaccard, N Troillet, S Harbarth, et al.
European Journal of Immunology|February 17, 1998
Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV CohortR A Morawetz, G P Rizzardi, D Glauser, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized studyG Zanetti, F Bally, G Greub, et al.
Pageof 25

Showing results (231-240 of 243) with videos related to

Sort By:
Pageof 25
European Heart Journal|October 1, 1985
Prophylaxis of infective endocarditis for dental procedures. Report of a working party of the European Society of CardiologyJ Delaye, J Etienne, G A Feruglio, et al.
Circulation|August 18, 1999
Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort StudyD Périard, A Telenti, P Sudre, et al.
Critical Care Medicine|July 9, 1999
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patientsP Eggimann, P Francioli, J Bille, et al.
Lancet (London, England)|July 13, 1985
Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipidJ D Baumgartner, M P Glauser, J A McCutchan, et al.
Critical Care Medicine|April 1, 1997
Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumoniaI de Werra, C Jaccard, S B Corradin, et al.
JAMA|May 21, 1997
p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study GroupE Abraham, M P Glauser, T Butler, et al.
The Pediatric Infectious Disease Journal|August 1, 1996
Empirical treatment of fever in neutropenic children: the role of the carbapenems. International Antimicrobial Therapy Cooperative Group of the European Organisation for Research and Treatment of Cancer and the Gimema Infection ProgramA Cometta, C Viscoli, E Castagnola, et al.
Antimicrobial Agents and Chemotherapy|October 31, 1998
Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitisC Jaccard, N Troillet, S Harbarth, et al.
European Journal of Immunology|February 17, 1998
Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV CohortR A Morawetz, G P Rizzardi, D Glauser, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized studyG Zanetti, F Bally, G Greub, et al.
Pageof 25